Sarepta Therapeutics (SRPT) Receivables - Other (2015 - 2026)
Sarepta Therapeutics' Receivables - Other was $45 million in Q2 2026, down 38.6% from $73.3 million a year earlier and down 67.0% from the prior quarter.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Receivables - Other (2015 - 2026) Analysis & Trends
At the end of FY2025, Receivables - Other at Sarepta Therapeutics came in at $104.1 million, up 200.9% from FY2024.
- Receivables - Other shows a five-year compound annual growth rate of 24.9% (FY2020 to FY2025).
- In earlier years, Receivables - Other was $34.6 million in FY2024 (+16.1%), $29.8 million in FY2023 (-28.7%), $41.8 million in FY2022 (+124.7%) and $18.6 million in FY2021 (-45.6%).
- The Q2 2026 figure marks the lowest quarterly Receivables - Other since Q4 2024.
- Compared with a year earlier, Receivables - Other was higher in seven of the last eight quarters, with growth averaging 107.3%.
- The best year-over-year quarter for Receivables - Other over five years was Q2 2025 (growth of 268.3%); the worst was Q1 2024 (a decline of 51.5%).
- Per Business Quant data, SRPT's Receivables - Other in the three quarters before Q2 2026 was $136.4 million (Q1 2026), $104.1 million (Q4 2025) and $128.7 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Sarepta Therapeutics | 1.99 Bn | -1.25 Bn | 251.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.00 Mn |
| Mar 31, 2026 | 136.40 Mn |
| Dec 31, 2025 | 104.10 Mn |
| Sep 30, 2025 | 128.70 Mn |
| Jun 30, 2025 | 73.30 Mn |
| Mar 31, 2025 | 55.20 Mn |
| Dec 31, 2024 | 34.60 Mn |
| Sep 30, 2024 | 66.40 Mn |
| Jun 30, 2024 | 19.90 Mn |
| Mar 31, 2024 | 30.10 Mn |
| Dec 31, 2023 | 29.80 Mn |
| Sep 30, 2023 | 35.40 Mn |
| Jun 30, 2023 | 28.60 Mn |
| Mar 31, 2023 | 62.00 Mn |
| Dec 31, 2022 | 41.80 Mn |
| Sep 30, 2022 | 21.90 Mn |
| Jun 30, 2022 | 26.40 Mn |
| Mar 31, 2022 | 17.70 Mn |
| Dec 31, 2021 | 18.60 Mn |
| Sep 30, 2021 | 29.10 Mn |
API Access
Sarepta Therapeutics Receivables - Other API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-other&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-other", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-other&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();